Key directions in mechanistic research related to PSMA’s role in the tumor microenvironment include investigating its involvement in angiogenesis and shaping immunosuppressive niches, which can inform combination therapies with anti-angiogenic or immunomodulatory agents (98). The gene discussed is FOLH1; the disease is neoplasm.